Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Iris Maria, Forte"'
Autor:
Aurora Costa, Iris Maria Forte, Francesca Pentimalli, Carmelina Antonella Iannuzzi, Luigi Alfano, Francesca Capone, Rosa Camerlingo, Alessandra Calabrese, Claudia von Arx, Reyes Benot Dominguez, Massimiliano Quintiliani, Michelino De Laurentiis, Andrea Morrione, Antonio Giordano
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionDiffuse pleural mesothelioma (DPM) of the pleura is a highly aggressive and treatment-resistant cancer linked to asbestos exposure. Despite multimodal treatment, the prognosis for DPM patients remains very poor, with an average survival o
Externí odkaz:
https://doaj.org/article/b853fb46d9b3462d81cf3795b07f7ee6
Autor:
Daniela Barone, Carmelina Antonella Iannuzzi, Iris Maria Forte, Maria Carmen Ragosta, Maria Cuomo, Milena Dell’Aquila, Angela Altieri, Antonella Caporaso, Rosa Camerlingo, Maria Manuela Rigano, Daria Maria Monti, Amalia Barone, Paola Imbimbo, Luigi Frusciante, Marcellino Monda, Margherita D’Angelo, Michelino De Laurentiis, Antonio Giordano, Luigi Alfano
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionDNA double-strand breaks are the most toxic lesions repaired through the non-homologous and joining (NHEJ) or the homologous recombination (HR), which is dependent on the generation of single-strand tails, by the DNA end resection mechani
Externí odkaz:
https://doaj.org/article/d8120edf9fa24bd2b25af9a7fb9d0a19
Autor:
Iris Maria Forte, Paola Indovina, Serena Montagnaro, Aurora Costa, Carmelina Antonella Iannuzzi, Francesca Capone, Rosa Camerlingo, Anna Maria Malfitano, Francesca Pentimalli, Gianmarco Ferrara, Massimiliamo Quintiliani, Giuseppe Portella, Antonio Giordano, Roberto Ciarcia
Publikováno v:
Viruses, Vol 13, Iss 12, p 2458 (2021)
Malignant mesothelioma (MM) is an aggressive asbestos-related cancer, against which no curative modalities exist. Oncolytic virotherapy is a promising therapeutic approach, for which MM is an ideal candidate; indeed, the pleural location provides dir
Externí odkaz:
https://doaj.org/article/8f3394d13d974c7ca2da05c47c64a3d5
Autor:
Sarah Di Somma, Carmelina Antonella Iannuzzi, Carmela Passaro, Iris Maria Forte, Raffaella Iannone, Vincenzo Gigantino, Paola Indovina, Gerardo Botti, Antonio Giordano, Pietro Formisano, Giuseppe Portella, Anna Maria Malfitano, Francesca Pentimalli
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Background: Malignant pleural mesothelioma (MPM) is an aggressive cancer associated with asbestos exposure that urgently requires effective therapeutic strategies. Current treatments are unable to increase significantly patient survival, which is oft
Externí odkaz:
https://doaj.org/article/a4d30345c67a43b790c451846bd62bbb
Autor:
Pierpaolo Correale, Rita Emilena Saladino, Diana Giannarelli, Andrea Sergi, Maria Antonietta Mazzei, Giovanna Bianco, Rocco Giannicola, Eleonora Iuliano, Iris Maria Forte, Natale Daniele Calandruccio, Antonia Consuelo Falzea, Alessandra Strangio, Valerio Nardone, Pierpaolo Pastina, Paolo Tini, Amalia Luce, Michele Caraglia, Daniele Caracciolo, Luciano Mutti, Pierfrancesco Tassone, Luigi Pirtoli, Antonio Giordano, Pierosandro Tagliaferri
Publikováno v:
Cells, Vol 9, Iss 9, p 1964 (2020)
Tumor-infiltrating T cell rescue by programmed cell death receptor-1 (PD-1)/PD-1 ligand-1 (PD-L1) immune checkpoint blockade is a recommended treatment for malignant diseases, including metastatic non-small-cell lung cancer (mNSCLC), malignant melano
Externí odkaz:
https://doaj.org/article/d23b3e92387b474e869261944ae728ba
Publikováno v:
The FASEB Journal. 36
Autor:
Luciano Mutti, Francesca Pentimalli, Marisa De Feo, Antonio Giordano, Cristiana Bellan, Enrico M. Bucci, Luca Luzzi, Paola Indovina, Simona De Summa, Eliseo Mattioli, Domenico Di Marzo, Carmelina Antonella Iannuzzi, Iris Maria Forte, Caterina Costa
Publikováno v:
Cell Death and Disease, Vol 11, Iss 9, Pp 1-15 (2020)
Cell Death & Disease
Cell Death & Disease
Malignant pleural mesothelioma (MPM) is an aggressive cancer, related to asbestos exposure, which has a dismal prognosis. MPM diagnosis is late and often challenging, suggesting the need to identify more reliable molecular biomarkers. Here, we set ou
Autor:
Benedetta Cinque, Michele d'Angelo, Annamaria Cimini, Massimiliano Quintiliani, Reyes Benot-Dominguez, Iris Maria Forte, Antonio Giordano, Rodolfo Ippoliti, Elisabetta Benedetti, Maria Grazia Cifone, Maria Grazia Tupone, Vanessa Castelli, Barbara Barboni
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 134, Iss, Pp 111139-(2021)
Breast and ovarian cancers are the leading and fifth reason for tumor death among females, respectively. Recently, many studies demonstrated antiproliferative activities of natural aliments in cancer. In this study, we investigated the antitumor pote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c19eeae7891a2c331c8cd33b8887c76c
http://hdl.handle.net/11697/152963
http://hdl.handle.net/11697/152963
Autor:
Gerardo Botti, Pietro Formisano, Carmela Passaro, Francesca Pentimalli, Paola Indovina, Raffaella Iannone, Antonio Giordano, Carmelina Antonella Iannuzzi, Anna Maria Malfitano, Iris Maria Forte, Giuseppe Portella, Sarah Di Somma, Vincenzo Gigantino
Publikováno v:
Frontiers in oncology (2019).
info:cnr-pdr/source/autori:Sarah Di Somma 1, Carmelina Antonella Iannuzzi 2, Carmela Passaro 1, Iris Maria Forte 2, Raffaella Iannone 1, Vincenzo Gigantino 3, Paola Indovina 4, Gerardo Botti 5, Antonio Giordano 4 6, Pietro Formisano 1, Giuseppe Portella 1, Anna Maria Malfitano 1, Francesca Pentimalli 2/titolo:The Oncolytic Virus dl 922-947 Triggers Immunogenic Cell Death in Mesothelioma and Reduces Xenograft Growth/doi:/rivista:Frontiers in oncology/anno:2019/pagina_da:/pagina_a:/intervallo_pagine:/volume
Frontiers in Oncology
Frontiers in Oncology, Vol 9 (2019)
info:cnr-pdr/source/autori:Sarah Di Somma 1, Carmelina Antonella Iannuzzi 2, Carmela Passaro 1, Iris Maria Forte 2, Raffaella Iannone 1, Vincenzo Gigantino 3, Paola Indovina 4, Gerardo Botti 5, Antonio Giordano 4 6, Pietro Formisano 1, Giuseppe Portella 1, Anna Maria Malfitano 1, Francesca Pentimalli 2/titolo:The Oncolytic Virus dl 922-947 Triggers Immunogenic Cell Death in Mesothelioma and Reduces Xenograft Growth/doi:/rivista:Frontiers in oncology/anno:2019/pagina_da:/pagina_a:/intervallo_pagine:/volume
Frontiers in Oncology
Frontiers in Oncology, Vol 9 (2019)
Background: Malignant pleural mesothelioma (MPM) is an aggressive cancer associated with asbestos exposure that urgently requires effective therapeutic strategies. Current treatments are unable to increase significantly patient survival, which is oft
Autor:
Antonia Consuelo Falzea, Amalia Luce, Maria Antonietta Mazzei, Giovanna Bianco, Rocco Giannicola, Eleonora Iuliano, Iris Maria Forte, Daniele Caracciolo, Luigi Pirtoli, Pierosandro Tagliaferri, Alessandra Strangio, Michele Caraglia, Rita Emilena Saladino, Paolo Tini, Pierpaolo Pastina, Antonio Giordano, Pierpaolo Correale, Andrea Sergi, Valerio Nardone, Diana Giannarelli, Pierfrancesco Tassone, Natale Daniele Calandruccio, Luciano Mutti
Publikováno v:
Cells
Volume 9
Issue 9
Cells, Vol 9, Iss 1964, p 1964 (2020)
Volume 9
Issue 9
Cells, Vol 9, Iss 1964, p 1964 (2020)
Tumor-infiltrating T cell rescue by programmed cell death receptor-1 (PD-1)/PD-1 ligand-1 (PD-L1) immune checkpoint blockade is a recommended treatment for malignant diseases, including metastatic non-small-cell lung cancer (mNSCLC), malignant melano